DVAX
Dynavax Technologies Corporation
NASDAQ: DVAX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$15.50
+0.00% today
Updated 2026-02-11
Market cap
$1.82B
P/E ratio
—
P/S ratio
5.51x
EPS (TTM)
$-0.37
Dividend yield
—
52W range
$9 – $16
Volume
3.5M
Dynavax Technologies Corporation (DVAX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$15.50
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.4B | $0.7B | $0.2B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -0.13%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.